article thumbnail

Reduced Co-Insurance for Screening Colonoscopies

Medisys Compliance

For dates of service calendar years 2027-2029, the reduced coinsurance is 10%. In addition, the ACA amended Section 1833(b)(1) of the Act to waive the Part B deductible for screening colonoscopies, which includes moderate sedation services as an inherent part of the screening colonoscopy procedural service.

article thumbnail

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027. Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. Political debates in this 2020 U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Begins Option to Extend Medicaid Postpartum Coverage

Healthcare Law Blog

This option is available for five years and ends on March 31, 2027. The new state plan option allows state Medicaid and Children’s Health Insurance Program (“CHIP”) agencies to provide 12 months of continuous postpartum coverage, regardless of any changes in circumstances, through a state plan amendment (“SPA”).

article thumbnail

Health Provider News

Hall Render

Ransomware attacks against hospitals put patients’ lives at risk, researchers say States, FTC continue to target noncompetes: 3 updates The best hospital in each state, per Newsweek What to know about Stark law’s $9.2M

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Healthcare Law Blog

Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Additional updates of note include: ACA Premium Tax Credit Eligibility. Annually thereafter, HHS will publish up to 20 additional negotiation-eligible Part D and Part B drugs. Negotiation-Eligible Drugs.